---
title: "RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment"
collection: publications
category: manuscripts
permalink: /publication/2024-08-27-rna-nanotherapeutics-mash
excerpt: 'This study develops a novel “Fibrosis Overexpression and Retention” (FORT) strategy combining retinoid‑derived lipid nanoparticles (LNPs) and collagen‑binding mRNA modifications to enhance targeted delivery and prolonged retention of therapeutic proteins in fibrotic livers, demonstrating potent anti‑fibrotic efficacy in multiple preclinical models of metabolic dysfunction‑associated steatohepatitis (MASH).'
date: 2024-08-27
venue: 'Nature Communications'
slidesurl: '#'
paperurl: 'https://doi.org/10.1038/s41467-024-51571-8'
bibtexurl: '#'
citation: 'Shan, X., Zhao, Z., Lai, P., Liu, Y., Li, B., Ke, Y., Jiang, H., Zhou, Y., Li, W., Wang, Q., Qin, P., Xue, Y., Zhang, Z., Wei, C., Ma, B., Liu, W., Luo, C., Lu, X., Lin, J., Shu, L., Jie, Y., Xian, X., Delcassian, D., Ge, Y., & Miao, L. (2024). RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment. Nature Communications, 15, 7263.'
---
